Inmaculada Robina

Dr. Inmaculada Robina

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2004 in Current Drug Metabolism
Verified
Journal Article
Closed access
PDF file
IRInmaculada Robina
Inmaculada Robina
AMAntonio J. Moreno-Vargas
Antonio J. Moreno-Vargas
ACAna Teresa Carmona
Ana Teresa Carmona
PVPierre Vogel
Pierre Vogel
A few α-L-fucosidase inhibitors and α-D-glucosidase inhibitors have shown in vitro anti-HIV activities, that have been attributed to their ability to inhibit HIV entry. The mechanism of action of inhibitors such as 1- deoxynojirimycin (1) is not clearly established. One possible hypothesis is that the glycosidase inhibition affects the final conformation of the glycoproteins involved in the virus / cell recognition and fusion phenomena. This hypothesis is presented critically and the mechanisms of some glycoprotein biosynthesis are out-lined. Up to now, very few glycosidase inhibitors have been assayed for their potential as HIV entry inhibitors. Further assaying should be done and larger collections of glycosidase inhibitors should be prepared. To help investigations in that perspective, the inhibitory activities of α-glucosidase and α-L-fucosidase inhibitors have been summarized.

11 October 2006 in Langmuir
Verified
Journal Article
Closed access
ARAmalia Rodríguez
Amalia Rodríguez
MGMaría del Mar Graciani
María del Mar Graciani
MMMaría Muñoz
María Muñoz
IRInmaculada Robina
Inmaculada Robina
María Luisa MoyáMaría Luisa Moyá
María Luisa Moyá

22 September 2003 in Helvetica Chimica Acta
Verified
Journal Article
Closed access
PDF file
ACAna Teresa Carmona
Ana Teresa Carmona
RWRichard H. Whigtman
Richard H. Whigtman
IRInmaculada Robina
Inmaculada Robina
Pierre VogelPierre Vogel
Pierre Vogel

1 December 2001 in Current Organic Chemistry
Verified
Journal Article
Closed access
IRInmaculada Robina
Inmaculada Robina
PVPierre Vogel
Pierre Vogel
ZWZbigniew Witczak
Zbigniew Witczak
As other monosaccharide mimics such as the azasugars and the carbasugars (with nitrogen and carbon atom, respectively, instead of oxygen atom in the ring) the thiosugars (with sulfur atom instead of oxygen atom in the ring) have gained importance in glycobiology and as potential drugs. Biological properties of monothiosaccharides are presented and the methods for their synthesis are reviewed and analyzed. Since the report of the synthesis of 5-thio-α-D-xylopyranose, the first example of thiosugars ever described, forty years of imaginative chemistry have produced a large number of monothiosaccharides and of analogs of biological interest. The preparative chemists have at their disposal a panoply of methodologies relying on pure chemical or on biochemical means, using carbohydrate or non-carbohydrate precursors. Because the sulfur moieties can participate more readily than the corresponding oxygen moieties in heterolytical processes, the chemistry of the thiosugars and their analogs is more sub tile and sometimes more delicate than that of the corresponding aldoses and alditols.

17 September 2001 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
FPFlorence Popowycz
Florence Popowycz
SGSandrine Gerber-Lemaire
Sandrine Gerber-Lemaire
RDRaynald Demange
Raynald Demange
EREliazar Rodriguez-Garcı́a
Eliazar Rodriguez-Garcı́a
ACAna Teresa Carmona
Ana Teresa Carmona
PVPierre Vogel
Pierre Vogel

2 May 2002 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
SGSandrine Gerber-Lemaire
Sandrine Gerber-Lemaire
FPFlorence Popowycz
Florence Popowycz
EREliazar Rodríguez-García
Eliazar Rodríguez-García
ACAna Teresa Carmona
Ana Teresa Carmona
IRInmaculada Robina
Inmaculada Robina
Pierre VogelPierre Vogel
Pierre Vogel